메뉴 건너뛰기




Volumn 38, Issue 6, 2014, Pages 756-767

Proposed morphologic classification of prostate cancer with neuroendocrine differentiation

Author keywords

Carcinoid; Large cell neuroendocrine carcinoma; Paneth cell like; Prostate adenocarcinonma; Small cell carcinoma

Indexed keywords

TUMOR MARKER;

EID: 84900836746     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000208     Document Type: Article
Times cited : (417)

References (81)
  • 1
    • 0033370811 scopus 로고    scopus 로고
    • Neuroendocrine cells in tumour growth of the prostate
    • Abrahamsson PA. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer. 1999;6:503-519
    • (1999) Endocr Relat Cancer , vol.6 , pp. 503-519
    • Abrahamsson, P.A.1
  • 2
    • 0023201899 scopus 로고
    • Peptidehormone-And serotonin-immunoreactive tumour cells in carcinoma of the prostate
    • Abrahamsson PA, Wadstrom LB, Alumets J, et al. Peptidehormone-And serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract. 1987;182:298-307
    • (1987) Pathol Res Pract , vol.182 , pp. 298-307
    • Abrahamsson, P.A.1    Wadstrom, L.B.2    Alumets, J.3
  • 3
    • 0027438929 scopus 로고
    • Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate
    • Bonkhoff H, Stein U, Remberger K. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch A Pathol Anat Histopathol. 1993;423:291-294
    • (1993) Virchows Arch A Pathol Anat Histopathol , vol.423 , pp. 291-294
    • Bonkhoff, H.1    Stein, U.2    Remberger, K.3
  • 4
    • 0015103480 scopus 로고
    • Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium
    • Azzopardi JG, Evans DJ. Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium. J Pathol. 1971;104:247-251
    • (1971) J Pathol , vol.104 , pp. 247-251
    • Azzopardi, J.G.1    Evans, D.J.2
  • 5
    • 0016253641 scopus 로고
    • Argentaffin and argyrophil cells in the prostate
    • Kazzaz BA. Argentaffin and argyrophil cells in the prostate. J Pathol. 1974;112:189-193
    • (1974) J Pathol , vol.112 , pp. 189-193
    • Kazzaz, B.A.1
  • 6
    • 1842788109 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in hormone refractory prostate cancer following androgen Deprivation therapy
    • Hirano D, Okada Y, Minei S, et al. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen Deprivation therapy. Eur Urol. 2004;45:586-592
    • (2004) Eur Urol , vol.45 , pp. 586-592
    • Hirano, D.1    Okada, Y.2    Minei, S.3
  • 7
    • 0344457271 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostatic carcinoma
    • Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Prostate. 1999;39:135-148
    • (1999) Prostate , vol.39 , pp. 135-148
    • Abrahamsson, P.A.1
  • 8
    • 26844531799 scopus 로고    scopus 로고
    • Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status
    • Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status. Prostate Suppl. 1998;8:18-22
    • (1998) Prostate Suppl , vol.8 , pp. 18-22
    • Bonkhoff, H.1
  • 9
    • 0025939537 scopus 로고
    • Relation of endocrineparacrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
    • Bonkhoff H, Wernert N, Dhom G, et al. Relation of endocrineparacrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate. 1991;19:91-98
    • (1991) Prostate , vol.19 , pp. 91-98
    • Bonkhoff, H.1    Wernert, N.2    Dhom, G.3
  • 10
    • 0035876175 scopus 로고    scopus 로고
    • Neuroendocrine cells in human prostate over-express the anti-Apoptosis protein survivin
    • Xing N, Qian J, Bostwick D, et al. Neuroendocrine cells in human prostate over-express the anti-Apoptosis protein survivin. Prostate. 2001;48:7-15
    • (2001) Prostate , vol.48 , pp. 7-15
    • Xing, N.1    Qian, J.2    Bostwick, D.3
  • 11
    • 34547699888 scopus 로고    scopus 로고
    • Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease
    • Berruti A, Mosca A, Porpiglia F, et al. Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease. J Urol. 2007;178: 838-843
    • (2007) J Urol , vol.178 , pp. 838-843
    • Berruti, A.1    Mosca, A.2    Porpiglia, F.3
  • 12
    • 0034065893 scopus 로고    scopus 로고
    • Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
    • Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol. 2000;31:406-414
    • (2000) Hum Pathol , vol.31 , pp. 406-414
    • Mucci, N.R.1    Akdas, G.2    Manely, S.3
  • 13
    • 79957443342 scopus 로고    scopus 로고
    • Abiraterone and increased survival in metastatic prostate cancer
    • de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl JMed. 2011; 364:1995-2005
    • (2011) N Engl JMed , vol.364 , pp. 1995-2005
    • De Bono, J.S.1    Logothetis, C.J.2    Molina, A.3
  • 14
    • 84866770294 scopus 로고    scopus 로고
    • Increased survival with enzalutamide in prostate cancer after chemotherapy
    • Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367: 1187-1197
    • (2012) N Engl J Med , vol.367 , pp. 1187-1197
    • Scher, H.I.1    Fizazi, K.2    Saad, F.3
  • 15
  • 16
    • 58149191580 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in the progression of prostate cancer
    • Komiya A, Suzuki H, Imamoto T, et al. Neuroendocrine differentiation in the progression of prostate cancer. Int J Urol. 2009; 16:37-44
    • (2009) Int J Urol , vol.16 , pp. 37-44
    • Komiya, A.1    Suzuki, H.2    Imamoto, T.3
  • 17
    • 12344252767 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
    • Vashchenko N, Abrahamsson PA. Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities. Eur Urol. 2005;47:147-155
    • (2005) Eur Urol , vol.47 , pp. 147-155
    • Vashchenko, N.1    Abrahamsson, P.A.2
  • 18
    • 0026601804 scopus 로고
    • Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer
    • Cohen RJ, Glezerson G, Haffejee Z. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer. Arch Pathol Lab Med. 1992;116:65-66
    • (1992) Arch Pathol Lab Med , vol.116 , pp. 65-66
    • Cohen, R.J.1    Glezerson, G.2    Haffejee, Z.3
  • 19
    • 20144388470 scopus 로고    scopus 로고
    • Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
    • Berruti A, Mosca A, Tucci M, et al. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relat Cancer. 2005;12:109-117
    • (2005) Endocr Relat Cancer , vol.12 , pp. 109-117
    • Berruti, A.1    Mosca, A.2    Tucci, M.3
  • 20
    • 0036719358 scopus 로고    scopus 로고
    • Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival
    • Bostwick DG, Qian J, Pacelli A, et al. Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival. J Urol. 2002;168:1204-1211
    • (2002) J Urol , vol.168 , pp. 1204-1211
    • Bostwick, D.G.1    Qian, J.2    Pacelli, A.3
  • 21
    • 0030722145 scopus 로고    scopus 로고
    • Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate
    • Theodorescu D, Broder SR, Boyd JC, et al. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer. 1997;80:2109-2119
    • (1997) Cancer , vol.80 , pp. 2109-2119
    • Theodorescu, D.1    Broder, S.R.2    Boyd, J.C.3
  • 22
    • 0030015190 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy
    • Weinstein MH, Partin AW, Veltri RW, et al. Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy. Hum Pathol. 1996;27:683-687
    • (1996) Hum Pathol , vol.27 , pp. 683-687
    • Weinstein, M.H.1    Partin, A.W.2    Veltri, R.W.3
  • 23
    • 0025901008 scopus 로고
    • Neuro-endocrine cells-A new prognostic parameter in prostate cancer
    • Cohen RJ, Glezerson G, Haffejee Z. Neuro-endocrine cells-A new prognostic parameter in prostate cancer. Br J Urol. 1991;68: 258-262
    • (1991) Br J Urol , vol.68 , pp. 258-262
    • Cohen, R.J.1    Glezerson, G.2    Haffejee, Z.3
  • 24
    • 33745822086 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostate cancer
    • Shariff AH, Ather MH. Neuroendocrine differentiation in prostate cancer. Urology. 2006;68:2-8
    • (2006) Urology , vol.68 , pp. 2-8
    • Shariff, A.H.1    Ather, M.H.2
  • 25
    • 0032322346 scopus 로고    scopus 로고
    • Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies
    • Casella R, Bubendorf L, Sauter G, et al. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. J Urol. 1998;160:406-410
    • (1998) J Urol , vol.160 , pp. 406-410
    • Casella, R.1    Bubendorf, L.2    Sauter, G.3
  • 26
    • 26844482718 scopus 로고    scopus 로고
    • Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma
    • Abrahamsson PA, Cockett AT, di Sant'Agnese PA. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma. Prostate Suppl. 1998;8:37-42
    • (1998) Prostate Suppl , vol.8 , pp. 37-42
    • Abrahamsson, P.A.1    Cockett, A.T.2    Di Sant'Agnese, P.A.3
  • 27
    • 0029047613 scopus 로고
    • Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
    • Allen FJ, Van Velden DJ, Heyns CF. Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?. Br J Urol. 1995;75:751-754
    • (1995) Br J Urol , vol.75 , pp. 751-754
    • Allen, F.J.1    Van Velden, D.J.2    Heyns, C.F.3
  • 28
    • 0033962683 scopus 로고    scopus 로고
    • Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
    • Ahlgren G, Pedersen K, Lundberg S, et al. Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate. 2000;42:274-279
    • (2000) Prostate , vol.42 , pp. 274-279
    • Ahlgren, G.1    Pedersen, K.2    Lundberg, S.3
  • 29
    • 0032982323 scopus 로고    scopus 로고
    • Prostate cancer and neuroendocrine differentiation
    • Tan MO, Karaoglan U, Celik B, et al. Prostate cancer and neuroendocrine differentiation. Int Urol Nephrol. 1999;31: 75-82
    • (1999) Int Urol Nephrol , vol.31 , pp. 75-82
    • Tan, M.O.1    Karaoglan, U.2    Celik, B.3
  • 30
    • 0028128330 scopus 로고
    • Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression
    • Cohen MK, Arber DA, Coffield KS, et al. Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer. 1994;74:1899-1903
    • (1994) Cancer , vol.74 , pp. 1899-1903
    • Cohen, M.K.1    Arber, D.A.2    Coffield, K.S.3
  • 31
    • 59649093542 scopus 로고    scopus 로고
    • Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer
    • Ishida E, Nakamura M, Shimada K, et al. Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer. Pathobiology. 2009;76:30-38
    • (2009) Pathobiology , vol.76 , pp. 30-38
    • Ishida, E.1    Nakamura, M.2    Shimada, K.3
  • 32
    • 84867404902 scopus 로고    scopus 로고
    • Neuroendocrine differentiation Does not have independent prognostic value in conservatively treated prostate cancer
    • Jeetle SS, Fisher G, Yang ZH, et al. Neuroendocrine differentiation Does not have independent prognostic value in conservatively treated prostate cancer. Virchows Arch. 2012;461:103-107
    • (2012) Virchows Arch , vol.461 , pp. 103-107
    • Jeetle, S.S.1    Fisher, G.2    Yang, Z.H.3
  • 33
    • 0028214994 scopus 로고
    • Neuroendocrine differentiation in metastatic prostatic adenocarcinoma
    • Aprikian AG, Cordon-Cardo C, Fair WR, et al. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol. 1994; 151:914-919
    • (1994) J Urol , vol.151 , pp. 914-919
    • Aprikian, A.G.1    Cordon-Cardo, C.2    Fair, W.R.3
  • 34
    • 0027319765 scopus 로고
    • Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
    • Aprikian AG, Cordon-Cardo C, Fair WR, et al. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer. 1993;71:3952-3965
    • (1993) Cancer , vol.71 , pp. 3952-3965
    • Aprikian, A.G.1    Cordon-Cardo, C.2    Fair, W.R.3
  • 35
    • 0026567030 scopus 로고
    • Paneth cell-like change of the prostate gland A histological, immunohistochemical, and electron microscopic study
    • Weaver MG, Abdul-Karim FW, Srigley J, et al. Paneth cell-like change of the prostate gland A histological, immunohistochemical, and electron microscopic study. Am J Surg Pathol. 1992;16:62-68
    • (1992) Am J Surg Pathol , vol.16 , pp. 62-68
    • Weaver, M.G.1    Abdul-Karim, F.W.2    Srigley, J.3
  • 36
    • 33747591682 scopus 로고    scopus 로고
    • Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate
    • Tamas EF, Epstein JI. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate. Am J Surg Pathol. 2006;30:980-985
    • (2006) Am J Surg Pathol , vol.30 , pp. 980-985
    • Tamas, E.F.1    Epstein, J.I.2
  • 37
    • 0028354268 scopus 로고
    • Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: Report of 30 cases
    • Adlakha H, Bostwick DG. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: Report of 30 cases. Hum Pathol. 1994;25:135-139
    • (1994) Hum Pathol , vol.25 , pp. 135-139
    • Adlakha, H.1    Bostwick, D.G.2
  • 38
    • 0742289499 scopus 로고    scopus 로고
    • Primary and pure neuroendocrine tumor of the prostate
    • Freschi M, Colombo R, Naspro R, et al. Primary and pure neuroendocrine tumor of the prostate. Eur Urol. 2004;45:166-169
    • (2004) Eur Urol , vol.45 , pp. 166-169
    • Freschi, M.1    Colombo, R.2    Naspro, R.3
  • 39
    • 78549264795 scopus 로고    scopus 로고
    • A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
    • Giordano S, Tolonen T, Tolonen T, et al A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Int Urol Nephrol. 2010;42:683-687
    • (2010) Int Urol Nephrol , vol.42 , pp. 683-687
    • Giordano, S.1    Tolonen, T.2    Tolonen, T.3
  • 40
    • 4544227669 scopus 로고    scopus 로고
    • Prostatic neuroendocrine tumor in multiple endocrine neoplasia type 2B
    • Goulet-Salmon B, Berthe E, Franc S, et al. Prostatic neuroendocrine tumor in multiple endocrine neoplasia type 2B. J Endocrinol Invest. 2004;27:570-573
    • (2004) J Endocrinol Invest , vol.27 , pp. 570-573
    • Goulet-Salmon, B.1    Berthe, E.2    Franc, S.3
  • 41
    • 0028952423 scopus 로고
    • Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child
    • Whelan T, Gatfield CT, Robertson S, et al. Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child. J Urol. 1995;153:1080-1082
    • (1995) J Urol , vol.153 , pp. 1080-1082
    • Whelan, T.1    Gatfield, C.T.2    Robertson, S.3
  • 42
    • 17844408444 scopus 로고    scopus 로고
    • Primary carcinoid tumour of the prostate
    • Zarkovic A, Masters J, Carpenter L. Primary carcinoid tumour of the prostate. Pathology. 2005;37:184-186
    • (2005) Pathology , vol.37 , pp. 184-186
    • Zarkovic, A.1    Masters, J.2    Carpenter, L.3
  • 43
    • 0022403084 scopus 로고
    • Carcinoid tumour of the prostate associated with inappropriate ACTH secretion
    • Slater D. Carcinoid tumour of the prostate associated with inappropriate ACTH secretion. Br J Urol. 1985;57:591-592
    • (1985) Br J Urol , vol.57 , pp. 591-592
    • Slater, D.1
  • 44
    • 0036093676 scopus 로고    scopus 로고
    • Metastatic carcinoid tumor of the prostate
    • Tash JA, Reuter V, Russo P. Metastatic carcinoid tumor of the prostate. J Urol. 2002;167:2526-2527
    • (2002) J Urol , vol.167 , pp. 2526-2527
    • Tash, J.A.1    Reuter, V.2    Russo, P.3
  • 45
    • 0018413615 scopus 로고
    • Primary carcinoid of prostate
    • Wasserstein PW, Goldman RL. Primary carcinoid of prostate. Urology. 1979;13:318-320
    • (1979) Urology , vol.13 , pp. 318-320
    • Wasserstein, P.W.1    Goldman, R.L.2
  • 46
    • 33750587865 scopus 로고    scopus 로고
    • Carcinoid tumors of the urinary tract and prostate
    • Murali R, Kneale K, Lalak N, et al. Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med. 2006;130:1693-1706
    • (2006) Arch Pathol Lab Med , vol.130 , pp. 1693-1706
    • Murali, R.1    Kneale, K.2    Lalak, N.3
  • 47
    • 0023734347 scopus 로고
    • Neuroendocrine differentiation in prostatic carcinomas A retrospective autopsy study
    • Turbat-Herrera EA, Herrera GA, Gore I, et al. Neuroendocrine differentiation in prostatic carcinomas A retrospective autopsy study. Arch Pathol Lab Med. 1988;112:1100-1105
    • (1988) Arch Pathol Lab Med , vol.112 , pp. 1100-1105
    • Turbat-Herrera, E.A.1    Herrera, G.A.2    Gore, I.3
  • 48
    • 0013508046 scopus 로고    scopus 로고
    • Mixed carcinoidadenocarcinoma of the prostate with spindle cell carcinoid: The spectrum of neuroendocrine differentiation in prostatic neoplasia
    • Egan AJM, Youngskin TP, Bostwick DG. Mixed carcinoidadenocarcinoma of the prostate with spindle cell carcinoid: The spectrum of neuroendocrine differentiation in prostatic neoplasia. Pathol Case Rev. 1996;1:65-69
    • (1996) Pathol Case Rev , vol.1 , pp. 65-69
    • Egan, A.J.M.1    Youngskin, T.P.2    Bostwick, D.G.3
  • 49
    • 84873736579 scopus 로고    scopus 로고
    • Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: A study of 7 cases
    • Lee S, Han JS, Chang A, et al. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: A study of 7 cases. Hum Pathol. 2013;44: 427-431
    • (2013) Hum Pathol , vol.44 , pp. 427-431
    • Lee, S.1    Han, J.S.2    Chang, A.3
  • 50
    • 0021929670 scopus 로고
    • Argyrophilic prostatic carcinoma. Case report with literature review on prostatic carcinoid and "carcinoid-like" prostatic carcinoma
    • Almagro UA. Argyrophilic prostatic carcinoma. case report with literature review on prostatic carcinoid and "carcinoid-like" prostatic carcinoma. Cancer. 1985;55:608-614
    • (1985) Cancer , vol.55 , pp. 608-614
    • Almagro, U.A.1
  • 51
    • 0021242938 scopus 로고
    • Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen
    • Azumi N, Shibuya H, Ishikura M. Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen. Am J Surg Pathol. 1984;8:545-550
    • (1984) Am J Surg Pathol , vol.8 , pp. 545-550
    • Azumi, N.1    Shibuya, H.2    Ishikura, M.3
  • 52
    • 0021223493 scopus 로고
    • Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature
    • Ghali VS, Garcia RL. Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. immunohistochemical study and review of the literature. Cancer. 1984;54: 1043-1048
    • (1984) Cancer , vol.54 , pp. 1043-1048
    • Ghali, V.S.1    Garcia, R.L.2
  • 53
    • 2142827112 scopus 로고    scopus 로고
    • Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: A case report
    • Ghannoum JE, DeLellis RA, Shin SJ. Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: A case report. Int J Surg Pathol. 2004;12:167-170
    • (2004) Int J Surg Pathol , vol.12 , pp. 167-170
    • Ghannoum, J.E.1    DeLellis, R.A.2    Shin, S.J.3
  • 54
    • 0022490255 scopus 로고
    • Prostatic adenocarcinoma evolving into carcinoid selective effect of hormonal treatment?
    • Stratton M, Evans DJ, Lampert IA. Prostatic adenocarcinoma evolving into carcinoid: Selective effect of hormonal treatment?. J Clin Pathol. 1986;39:750-756
    • (1986) J Clin Pathol , vol.39 , pp. 750-756
    • Stratton, M.1    Evans, D.J.2    Lampert, I.A.3
  • 55
    • 0023491240 scopus 로고
    • Prostatic carcinoma with endocrine features A report of a neoplasm containing multiple immunoreactive hormonal substances
    • Rojas-Corona RR, Chen LZ, Mahadevia PS. Prostatic carcinoma with endocrine features A report of a neoplasm containing multiple immunoreactive hormonal substances. Am J Clin Pathol. 1987;88: 759-762
    • (1987) Am J Clin Pathol , vol.88 , pp. 759-762
    • Rojas-Corona, R.R.1    Chen, L.Z.2    Mahadevia, P.S.3
  • 56
    • 0018777971 scopus 로고
    • Carcinoid tumor of the prostate associated with adenocarcinoma
    • Montasser AY, Ong MG, Mehta VT. Carcinoid tumor of the prostate associated with adenocarcinoma. Cancer. 1979;44:307-310
    • (1979) Cancer , vol.44 , pp. 307-310
    • Montasser, A.Y.1    Ong, M.G.2    Mehta, V.T.3
  • 57
    • 21644444448 scopus 로고    scopus 로고
    • Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
    • Reyes A, Moran CA. Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Arch Pathol Lab Med. 2004;128:e166-e168
    • (2004) Arch Pathol Lab Med , vol.128
    • Reyes, A.1    Moran, C.A.2
  • 58
    • 0022618142 scopus 로고
    • Prostatic acid phosphatase activity in carcinoid tumors
    • Sobin LH, Hjermstad BM, Sesterhenn IA, et al. Prostatic acid phosphatase activity in carcinoid tumors. Cancer. 1986;58: 136-138
    • (1986) Cancer , vol.58 , pp. 136-138
    • Sobin, L.H.1    Hjermstad, B.M.2    Sesterhenn, I.A.3
  • 59
    • 37549037864 scopus 로고    scopus 로고
    • Small cell carcinoma of the prostate A morphologic and immunohistochemical study of 95 cases
    • Wang W, Epstein JI. Small cell carcinoma of the prostate A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol. 2008;32:65-71
    • (2008) Am J Surg Pathol , vol.32 , pp. 65-71
    • Wang, W.1    Epstein, J.I.2
  • 60
    • 0023191097 scopus 로고
    • Small cell carcinoma of the prostate part I A clinicopathologic study of 20 cases
    • Tetu B, Ro JY, Ayala AG, et al. Small cell carcinoma of the prostate. part I A clinicopathologic study of 20 cases. Cancer. 1987; 59:1803-1809
    • (1987) Cancer , vol.59 , pp. 1803-1809
    • Tetu, B.1    Ro, J.Y.2    Ayala, A.G.3
  • 61
    • 33745890595 scopus 로고    scopus 로고
    • Small cell carcinoma of the prostate: An immunohistochemical study
    • Yao JL, Madeb R, Bourne P, et al. Small cell carcinoma of the prostate: An immunohistochemical study. Am J Surg Pathol. 2006; 30:705-712
    • (2006) Am J Surg Pathol , vol.30 , pp. 705-712
    • Yao, J.L.1    Madeb, R.2    Bourne, P.3
  • 62
    • 0023095325 scopus 로고
    • Small cell carcinoma of the prostate II immunohistochemical and electron microscopic studies of 18 cases
    • Ro JY, Tetu B, Ayala AG, et al. Small cell carcinoma of the prostate II immunohistochemical and electron microscopic studies of 18 cases. Cancer. 1987;59:977-982
    • (1987) Cancer , vol.59 , pp. 977-982
    • Ro, J.Y.1    Tetu, B.2    Ayala, A.G.3
  • 63
    • 0034075111 scopus 로고    scopus 로고
    • Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors
    • Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000;13:238-242
    • (2000) Mod Pathol , vol.13 , pp. 238-242
    • Agoff, S.N.1    Lamps, L.W.2    Philip, A.T.3
  • 64
    • 0033843564 scopus 로고    scopus 로고
    • Value of thyroid transcription factor-1 immunostaining in Distinguishing small cell lung carcinomas from other small cell carcinomas
    • Ordonez NG. Value of thyroid transcription factor-1 immunostaining in Distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol. 2000;24:1217-1223
    • (2000) Am J Surg Pathol , vol.24 , pp. 1217-1223
    • Ordonez, N.G.1
  • 65
    • 27344451557 scopus 로고    scopus 로고
    • Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
    • Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648
    • (2005) Science , vol.310 , pp. 644-648
    • Tomlins, S.A.1    Rhodes, D.R.2    Perner, S.3
  • 66
    • 79957912763 scopus 로고    scopus 로고
    • ERG gene rearrangements are common in prostatic small cell carcinomas
    • Lotan TL, Gupta NS, Wang W, et al. ERG gene rearrangements are common in prostatic small cell carcinomas.Mod Pathol. 2011;24:820-828
    • (2011) Mod Pathol , vol.24 , pp. 820-828
    • Lotan, T.L.1    Gupta, N.S.2    Wang, W.3
  • 67
    • 68249083702 scopus 로고    scopus 로고
    • Fluorescence in situ hybridization study shows association of PTEN Deletion with ERG rearrangement during prostate cancer progression
    • Han B, Mehra R, Lonigro RJ, et al. Fluorescence in situ hybridization study shows association of PTEN Deletion with ERG rearrangement during prostate cancer progression. Mod Pathol. 2009;22:1083-1093
    • (2009) Mod Pathol , vol.22 , pp. 1083-1093
    • Han, B.1    Mehra, R.2    Lonigro, R.J.3
  • 68
    • 78649987427 scopus 로고    scopus 로고
    • TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate
    • Guo CC, Dancer JY, Wang Y, et al. TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. Hum Pathol. 2011;42:11-17
    • (2011) Hum Pathol , vol.42 , pp. 11-17
    • Guo, C.C.1    Dancer, J.Y.2    Wang, Y.3
  • 69
    • 79961031503 scopus 로고    scopus 로고
    • ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin
    • Williamson SR, Zhang S, Yao JL, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin. Mod Pathol. 2011;24:1120-1127
    • (2011) Mod Pathol , vol.24 , pp. 1120-1127
    • Williamson, S.R.1    Zhang, S.2    Yao, J.L.3
  • 70
    • 77953200272 scopus 로고    scopus 로고
    • ERG rearrangement in small cell prostatic and lung cancer
    • Scheble VJ, Braun M, Wilbertz T, et al. ERG rearrangement in small cell prostatic and lung cancer. Histopathology. 2010;56:937-943
    • (2010) Histopathology , vol.56 , pp. 937-943
    • Scheble, V.J.1    Braun, M.2    Wilbertz, T.3
  • 71
    • 84884418404 scopus 로고    scopus 로고
    • Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: The superiority of fluorescence in situ hybridization over ERG immunohistochemistry
    • Schelling LA, Williamson SR, Zhang S, et al. Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: The superiority of fluorescence in situ hybridization over ERG immunohistochemistry. Hum Pathol. 2013;44:2227-2233
    • (2013) Hum Pathol , vol.44 , pp. 2227-2233
    • Schelling, L.A.1    Williamson, S.R.2    Zhang, S.3
  • 72
    • 84857657168 scopus 로고    scopus 로고
    • Survival of patients with small cell carcinoma of the prostate during 1973- 2003 A populationbased study
    • Deorah S, Rao MB, Raman R, et al. Survival of patients with small cell carcinoma of the prostate during 1973-2003: A populationbased study. BJU Int. 2012;109:824-830
    • (2012) BJU Int , vol.109 , pp. 824-830
    • Deorah, S.1    Rao, M.B.2    Raman, R.3
  • 73
    • 0026550416 scopus 로고
    • Chemotherapy for small cell carcinoma of prostatic origin
    • Amato RJ, Logothetis CJ, Hallinan R, et al. Chemotherapy for small cell carcinoma of prostatic origin. J Urol. 1992;147:935-937
    • (1992) J Urol , vol.147 , pp. 935-937
    • Amato, R.J.1    Logothetis, C.J.2    Hallinan, R.3
  • 74
    • 0030811134 scopus 로고    scopus 로고
    • Small cell anaplastic carcinoma of the prostate: Seven new cases, review of the literature, and discussion of a therapeutic strategy
    • Rubenstein JH, Katin MJ, Mangano MM, et al. Small cell anaplastic carcinoma of the prostate: Seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol. 1997;20:376-380
    • (1997) Am J Clin Oncol , vol.20 , pp. 376-380
    • Rubenstein, J.H.1    Katin, M.J.2    Mangano, M.M.3
  • 75
    • 84879853237 scopus 로고    scopus 로고
    • Platinum-based chemotherapy for variant castrate-resistant prostate cancer
    • Aparicio AM, Harzstark AL, Corn PG, et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013;19:3621-3630
    • (2013) Clin Cancer Res , vol.19 , pp. 3621-3630
    • Aparicio, A.M.1    Harzstark, A.L.2    Corn, P.G.3
  • 76
    • 0037099524 scopus 로고    scopus 로고
    • Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate
    • Papandreou CN, Daliani DD, Thall PF, et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol. 2002;20:3072-3080
    • (2002) J Clin Oncol , vol.20 , pp. 3072-3080
    • Papandreou, C.N.1    Daliani, D.D.2    Thall, P.F.3
  • 77
    • 35948929512 scopus 로고    scopus 로고
    • Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells
    • Yuan TC, Veeramani S, Lin MF. Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer. 2007;14:531-547
    • (2007) Endocr Relat Cancer , vol.14 , pp. 531-547
    • Yuan, T.C.1    Veeramani, S.2    Lin, M.F.3
  • 78
    • 84860168795 scopus 로고    scopus 로고
    • Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
    • Beltran H, Rickman DS, Park K, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 2011;1:487-495
    • (2011) Cancer Discov , vol.1 , pp. 487-495
    • Beltran, H.1    Rickman, D.S.2    Park, K.3
  • 79
    • 33745895892 scopus 로고    scopus 로고
    • Large cell neuroendocrine carcinoma of prostate: A clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer
    • Evans AJ, Humphrey PA, Belani J, et al. Large cell neuroendocrine carcinoma of prostate: A clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol. 2006;30:684-693
    • (2006) Am J Surg Pathol , vol.30 , pp. 684-693
    • Evans, A.J.1    Humphrey, P.A.2    Belani, J.3
  • 80
    • 79953701350 scopus 로고    scopus 로고
    • Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles
    • Aparicio A, Tzelepi V, Araujo JC, et al. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles. Prostate. 2011;71:846-856
    • (2011) Prostate , vol.71 , pp. 846-856
    • Aparicio, A.1    Tzelepi, V.2    Araujo, J.C.3
  • 81
    • 84873048485 scopus 로고    scopus 로고
    • Concurrent aurka and mycn gene amplifications are harbingers of lethal treatmentrelated neuroendocrine prostate cancer
    • Mosquera JM, Beltran H, Park K, et al. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatmentrelated neuroendocrine prostate cancer. Neoplasia. 2013;15:1-10.
    • (2013) Neoplasia , vol.15 , pp. 1-10
    • Mosquera, J.M.1    Beltran, H.2    Park, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.